C12Y 207/0105
Hydroxyethylthiazole kinase
Official title: Hydroxyethylthiazole kinase (2.7.1.50)
C12Y207/0105 (Hydroxyethylthiazole kinase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 5
- Inventors
- 10
- Latest grant
- 10 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
By publication year.
Recent patents
- Recombinant production of cannabinoids26 Sep 2024US 2024/0318211 A11000128725 Ontario Inc.
- Biosynthesis of substituted compounds and cannabinoids7 Mar 2024US 2024/0076699 A1Invizyne Technologies, Inc.
- Improved methods for producing lsobutene from 3-methylcrotonic acid9 Sep 2021US 2021/0277425 A1Global Bioenergies
- Methods for the enzymatic production of isoprene from isoprenol8 Oct 2015US 2015/0284743 A1Global Bioenergies
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.